Improvement of quality of life in menopause under the influence of Femo-Clim drug

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The influence of a natural non-hormonal remedy “Femo-Klim” on the quality of life (QOL) of 47 menopausal women with a reduced level of sex hormones was studied. The Short Form 36 Health Quality Survey questionnaire was used. “Femo-Klim” was found to be an effective drug in the treatment of menopausal manifestations in women with altered hormonal background and to have a positive effect on their quality of life.

Full Text

Restricted Access

About the authors

Dmitry G. Elistratov

Medical center «Secrets of longevity»

Email: dge117@mail.ru
ORCID iD: 0000-0001-7809-480X

General Director

Russian Federation, Penza

Mark D. Shamilov

Urals State Medical University

Author for correspondence.
Email: dge117@mail.ru

the 4th year student of the faculty of treatment and prevention

Russian Federation, Yekaterinburg

References

  1. Blumel J.E., Castello C. Et al. Quality of life after the menopause - a population study Maturitas. 2009.vol.34.P.17-23.
  2. Khabibulina MM. Impact of hypoestrogenemia on quality of life in women with arterial hypertension during premenopause Cardiology. 2013. 53 (11): 45-48.
  3. Khabibulina MM, Dmitriev AN, Fedorova N.N. Quality of life of young women with arterial hypertension with hypoestrogenemia with «metabolically healthy» visceral obesity. Eurasian Union of Scientists. 2017. 1(34): 25-29
  4. Khabibulina MM, Shamilov MD Quality of life of young women with arterial hypertension and altered hormonal background Phys. 2021. 32(1): 46-49.
  5. Chazova I.E., Smetnik V.P., Balan V.E. Management of women with cardiovascular risk in peri- and postmenopause: consensus of Russian cardiologists and gynecologists Consiliummedicum.2008; 10(6): 5-18
  6. Skornyakova M.N., Syrochkina M.A. Hypomenstrual syndrome // Manual for physicians. Yekaterinburg. 2008. 236 с.
  7. Smetnik V.P., Ilyina L.M. The correction of the menopausal syndrome (individualization of therapy) in the book «Medicine of menopause». 2006. ed. «Litera», 217-274.
  8. Khabibulina MM. Cardiovascular risk in estrogen deficiency in premenopausal periods //Ekaterinburg. 2014.
  9. Palacios S.,Berrego R. The importance of preventive health care in postmenopausal women Maturas.2005.Vol.52.S.53-60.
  10. Rapeport N. Cardiovascular disease and hormone replacement therapy in postmenopausal women Cardiovascular J.S. 2005. Vol.16. 2. P.76-80.
  11. Stein K.D., Jacobsen P.B.. Effect of hot flashes on quality of life among postmenopausal women being treated for breast cancerJ. Pain.Symptom.2009. vol.19. P.436-445.
  12. Menopausal hormone therapy and the preservation of mature women’s health: Clinical guidelines (treatment protocol). Moscow: FGBU NCHAIP, 2015.
  13. Hsia J, Langer RD, Manson JE, et al; Women’s Health Initiative Investigators. Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Arch Intern Med 2006; 166: 357-65).
  14. Pines A., Sturdee DW, Birkhauser M.H.. IMS Updated Recommendations on postmenopausal hormone therapy. Climacteric 2007; 10: 195-196
  15. Habibulina M.M. Structural and geometric changes in the left ventricle, endothelium-dependent vasodilation of peripheral arteries, the antihypertensive effect of angiotensin-converting enzyme inhibitors and hormone replacement therapy in women with arterial hypertension in premenopause Cardiovascular therapy and prevention. 2011.10 (2): 24-28.
  16. Khabibulina M.M., Dmitriev A.N. Method for optimization of treatment of women by cardiotropic therapy and hormone replacement therapy for estrogen deficiency with arterial hypertension in the late reproductive period // Patent for invention RU2648470 C2, 26.03.2018. Application №2016107890 of 03.03.2016.
  17. Khabibulina MM Therapy in women with arterial hypertension and estrogen deficiency in the late fertile period Phys. 2016. 4: 45-49.
  18. Khabibulina M.M. Premenopause: the effect of diroton and ZGT therapy on quality of life in arterial hypertension Vrach. 2012. 7: 69-71.
  19. Khabibulina MM, Smolentseva AA Therapy of anxiety disorders in women with arterial hypertension during premenopause at the outpatient stage In the collection: V Congress of Cardiologists of the Urals Federal District. Materials of the Congress. 2011. 282-284.
  20. Novik A.A. Guidelines for the study of quality of life in medicine / A.A. Novik, T.I. Ionova. - Saint-Petersburg: Publishing house «Neva»; M.: «OLMA-PRESS Star World», 2002. - 320 с.
  21. Ware J.E. Measuring patients’ views: the optimum outcome measure. SF 36: a valid, reliable assessment of health from the patient’s point of view / J.E. Ware BMJ. - 1999. - Vol. 306. - Р. 1429-1430.
  22. Ware J. Overview of the SF-36 Health Surveg and the International anality of Life Assessment (JQOLA) / J. Ware, B. Gandek Projekt J. Clin. Epidemiology. - 1998. - Vol. 11. - P. 903-912.
  23. The WHOQOL Group. What Quality of Life? / The WHOQOL Group World Health Forum. - 1996. - Vol. 17. - P. 354-356.
  24. Ovsyannikova T.V., Makarov I.O., Kulikov I.A. Clinical efficacy of non-hormonal methods of therapy in women in perimenopause Obstetrics, Gynecology, Reproduction. 2013; 7(3): 26-9
  25. Petrova E., Kalistratov V., Poluboyarinov P., et al. Femo-Clim used in menopause - the best non-hormonal solution to hormonal problems Phys. 2019; 2: 46-49.
  26. Khabibulina MM, Shamilov MD The effect of glycine and lisinopril on the quality of life of women with arterial hypertension and estrogen deficiency Phys. 2021.32 (4): 38-42.
  27. Potupchik T., Veselova O., Evert L., et al. Spectrum of pharmacological effects of glycine. Phys. 2015; 12: 14-17.
  28. Radzinsky V.E., Dobretsova T.A. Menopause as a mechanism of female aging. Phytoestrogens - reconnaissance battle StatusPraesens. Gynecology. Obstetrics. Infertile marriage. 2015; 2 (25): 51-58.
  29. Radzinsky VE, Dobretsova TA, Ryzhova TE Biological role of the menopausal transition and therapeutic potential of phytoestrogens StatusPraesens. Gynecology. Obstetrics. Infertile marriage. 2015; 4 (27): 77-82.
  30. Tatarova NA, Linde VA, Zhidkova EV, et al. Non-hormonal correction of menopausal disorders in peri- and postmenopause Effective pharmacotherapy in obstetrics and gynecology. 2009; 17: 12–15.
  31. Strukov V.I., Sergeeva-Kondrachenko M.Yu., Marchenkova L.A., etc. Immunotherapy of postmenopausal osteoporosis and other diseases of the osteoarticular system against the background of hormonal insufficiency Obstetrics and gynecology: news, opinions, training. 2022. 10(2): 14–22
  32. Strukov V., Elistratov D., Kislov A. et al. Osteoporosis in geriatric practice Vrach. 2018, 29 (6): 26-30.
  33. Sergeeva-Kondrachenko M., Strukov V., Poluboyarinov P. et al. Type 2 diabetes mellitus and postmenopausal osteoporosis: how to improve quality of life? Vrach. 2019, 30 (11): 72-75
  34. Sergeeva-Kondrachenko M.Y. Treatment of women with menopausal syndrome: an alternative to menopausal hormone therapy. Vrach. 2022; 33 (7): 35–40.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1

Download (134KB)
Indexing metadata

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies